Asmaa Elbakry

Asmaa Elbakry

Auto-generated profile, based on publicly available information

Asmaa Elbakry

Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2009 in Nano Letters
Verified
Journal Article
Closed access
AEAsmaa Elbakry
Asmaa Elbakry
AZAlaa Zaky
Alaa Zaky
RLRenate Liebl
Renate Liebl
RRReinhard Rachel
Reinhard Rachel
AGAchim Goepferich
Achim Goepferich
MBMiriam Breunig
Miriam Breunig

22 August 2012 in Small
Verified
Journal Article
Closed access
PDF file
AEAsmaa Elbakry
Asmaa Elbakry
EWEva‐Christina Wurster
Eva‐Christina Wurster
AZAlaa Zaky
Alaa Zaky
RLRenate Liebl
Renate Liebl
ESEdith Schindler
Edith Schindler
MBMiriam Breunig
Miriam Breunig

5 May 2016 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PDF file
Ahmed A. H. AbdellatifAhmed A. H. Abdellatif
Ahmed A. H. Abdellatif
GZGamal Zayed
Gamal Zayed
AEAsmaa El-Bakry
Asmaa El-Bakry
AZAlaa Zaky
Alaa Zaky
ISImran Y. Saleem
Imran Y. Saleem
HTHesham M. Tawfeek
Hesham M. Tawfeek
Targeting of G-protein coupled receptors (GPCRs) like somatostatin-14 (SST-14) could have a potential interest in delivery of anti-cancer agents to tumor cells. Attachment of SST to different nano-carriers e.g., polymeric nanoparticles is limited due to the difficulty of interaction between SST itself and those nano-carriers. Furthermore, the instability problems associated with the final formulation. Attaching of SST to gold nanoparticles (AuNPs) using the positive and negative charge of SST and citrate-AuNPs could be considered a new technique to get stable non-aggregated AuNPs coated with SST. Different analyses techniques have been performed to proof the principle of coating between AuNPs and SST. Furthermore, cellular uptake study on HCC-1809 cell lines has been investigated to show the ability of AuNPs coated SST to enter the cells via SST receptors. Dynamic light scattering (DLS) indicated a successful coating of SST on the MUA-AuNPs surface. Furthermore, all the performed analysis including DLS, SDS-PAGE and UV-VIS absorption spectra indicated a successful coating of AuNPs with SST. Cellular uptake study on HCC-1806 cell lines showed that the number of AuNPs-SST per cell is significantly higher compared to citrate-AuNPs when quantified using inductively coupled plasma spectroscopy. Moreover, the binding of AuNPs-SST to cells can be suppressed by addition of antagonist, indicating that the binding of AuNPs-SST to cells is due to receptor-specific binding. In conclusion, AuNPs could be attached to SST via adsorption to get stable AuNPs coated SST. This new formulation has a potential to target SST receptors localized in many normal and tumor cells.

14 November 2017 in Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
ARAfaf A. Ramadan
Afaf A. Ramadan
AEAsmaa M. Elbakry
Asmaa M. Elbakry
AEAsmaa H. Esmaeil
Asmaa H. Esmaeil
SKSahar A. Khaleel
Sahar A. Khaleel
The objective of the present study was to develop rectal mucoadhesive hydrogels loaded with Tolmetin Sodium, a non-steroidal anti-inflammatory drug, for prolonged duration of action and increased bioavailability. Fourteen formulae were prepared with different types and concentrations of polymers as hydroxypropylmethyl cellulose, hydroxylethyl cellulose, carboxymethyl cellulose and sodium alginate. Each formulation contain Tolmetin Sodium equivalent to 5% w/w active drug. The effect of the employed gel bases on pH, gel strength, mucoadhesion, viscosity and the in vitro release profile of drug was examined. In addition, hydrogel formulations were subjected to rheological and stability studies. The physicochemical characterization revealed that all hydrogels had a suitable pH (6.64–7.75) and gel strength (15.5–65.29 s) for rectal application. The in-vitro drug release from the formulations showed a controlled drug release pattern, reaching 72–92.6% after 8 h. The kinetic analysis of the release data revealed that the drug release from all tested hydrogel bases obeyed the diffusion mechanism. The degradation of Tolmetin Sodium from its rectal hydrogel formulations was found to be a zero-order reaction. All formulations except sodium alginate hydrogel were quite stable. Considering the in-vitro release, rheological properties and shelf life, (CMC; 2%w/w) hydrogel formula was the best among the studied formulations. Therefore, further histopathological and bioavailability studies were carried out to detect different pharmacokinetic parameters of the established formulations compared with commercially available capsules. Formula containing 2% CMC showed relative bioavailability 357.93%. Finally, good correlation was observed between in-vitro and in-vivo profile.

1 October 2010 in Journal of Controlled Release
Verified
Journal Article
Closed access
AZA. Zaky
A. Zaky
AEA. Elbakry
A. Elbakry
AEA. Ehmer
A. Ehmer
MBMiriam Breunig
Miriam Breunig
AGA. Goepferich
A. Goepferich

14 September 2012
Verified
Book Chapter
Closed access
PDF file
EWEva-Christina Wurster
Eva-Christina Wurster
AEAsmaa Elbakry
Asmaa Elbakry
AGAchim Göpferich
Achim Göpferich
MBMiriam Breunig
Miriam Breunig